Newsroom - BioNTech
WEBWelcome to the BioNTech Newsroom. In this section you can find a variety of media materials and useful information to download. Media Downloads. Conference "Working Together to Promote Vaccine Equity for Africa", December 18, 2023. Africa Vaccine Equity Conference 1. Africa Vaccine Equity Conference 2. Africa Vaccine Equity Conference 3.
BioNTech Announces Positive Topline Phase 2 Results for mRNA ...
WEBJul 30, 2024 — BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma. 30 July 2024. PDF Version. Primary endpoint met in a Phase 2 trial evaluating the investigational mRNA immunotherapy BNT111 in combination with the PD-1 checkpoint inhibitor cemiplimab.
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBSep 22, 2021 — NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 …
Pfizer and BioNTech Provide Update on mRNA-based …
WEBAug 16, 2024 — NEW YORK & MAINZ, Germany, August 16, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced top-line results from their Phase 3 clinical trial to...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBDec 11, 2020 — NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY ® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older.
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 — Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school...
US FDA authorizes Pfizer-BioNTech and Moderna's updated …
WEBSept 11 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N) /BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a recently...
BioNTech Highlights AI Capabilities and R&D Use Cases at …
WEB6 days ago — Press Release. BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day. LONDON, United Kingdom, October 1, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), alongside its artificial intelligence (“AI”) subsidiary InstaDeep Ltd. (“InstaDeep”), today presents an overview of …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 — Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 trial evaluating the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-19 ...
BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo …
WEBGet the latest BioNTech SE (BNTX) stock news and headlines to help you in your trading and investing decisions.